Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Jul 09, 2019
TickeronGET DAILY SIGNALS
Trending lower, 50-day looming as resistance, and a bearish signal for Mylan

Trending lower, 50-day looming as resistance, and a bearish signal for Mylan

Generic drug manufacturer Mylan (Nasdaq: MYL) has been trending lower for the last year and a half. The company has struggled and the stock reflects that. We see on the daily chart how a trend channel has formed that defines the overall trend in the past year.

Normally I point out when a stock is hitting the upper rail of a downward sloping channel, but in the case of Mylan, it is only at the midpoint of the channel. Because the stock fell so sharply in May, the stock is in overbought territory and yet is in the middle of the channel.

We see that the 50-day moving average is just over head and that resistance could be the catalyst for the next move down. The daily stochastic readings are in overbought territory and made a bearish crossover on July 8.

The Tickeron Trend Prediction Engine generated a bearish signal on Mylan on July 5 with a confidence level of 85%. The signal calls for a decline of at least 4% within the next month and previous predictions on the stock have been successful 79% of the time.

Mylan’s fundamental readings show that earnings have been flat over the last three years and declined by 15% in the most recent quarter. Analysts expect earnings to decline by 6% in 2019. Sales have grown by only 5% per year over the last three years and they declined by 7% in the most recent quarter.

Related Ticker: MYL

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceuticals

Industry NotClassified

Industry
Pharmaceuticals Generic
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.
Trending lower, 50-day looming as resistance, and a bearish signal for Mylan